3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Paraparesis, Tropical Spastic
1
Opportunistic Infections
1
Neuritis
1
Leukemia-Lymphoma, Adult T-Cell
1
Inflammation
1
HTLV-I Infections
1
Epstein-Barr Virus Infections
1
Cytomegalovirus Infections
1
Coinfection
1
Acquired Immunodeficiency Syndrome
1
Interventions
Nivolumab
2
prednylidene
1
peginterferon alfa-2b
1
dolutegravir
1
deltacortene
1
Zidovudine
1
Vincristine
1
Valproic Acid
1
Tenofovir
1
Specimen Handling
1
Prednisone
1
Pharmacogenomic Testing
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Interferon alpha-2
1
Etoposide
1
Doxorubicin
1
Daclizumab
1
Cyclophosphamide
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
HTLV-I Infections
×
dolutegravir
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled